Marijuana also known as Cannabis among other names, is a psychoactive drug from the cannabis plant. Native to Central or South Asia, the cannabis plant has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries.
Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis, which is one of the four hundred and eighty three known compounds in the plant, including at least sixty five other cannabinoids, such as cannabidiol (CBD). Cannabis can be used by smoking, vaporizing, within food, or as an extract.
Marijuana has various mental and physical effects, which include euphoria, altered states of mind and sense of time, difficulty concentrating, impaired short-term memory, impaired body movement (balance and fine psychomotor control), relaxation, and an increase in appetite.
Onset of effects is felt within minutes when smoked, but may take up to ninety minutes when eaten. The effects last for two to six hours, depending on the amount used. At high doses, mental effects can include anxiety, delusions (including ideas of reference), hallucinations, panic, paranoia, and psychosis.
There is a strong relation between cannabis use and the risk of psychosis, though the direction of causality is debated. Physical effects include increased heart rate, difficulty breathing, nausea, and behavioral problems in children whose mothers used cannabis during pregnancy; short-term side effects may also include dry mouth and red eyes.
The Global Marijuana Grow Kits Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Aurora and MedReleaf Australia Launch new Medical Marijuana Brand – CraftPlant
The Canadian company opening the world to cannabis, and MedReleaf Australia announced the launch of CraftPlant, a new medical cannabis brand for patients in the Australian market. The CraftPlant brand includes three new products available for doctors to prescribe – Greendae, Navana and HiVolt.
All three are developed from ultra-premium cultivars and are THC-dominant with high percentages of terpenes. The cultivars were developed by Occo, Aurora’s leading science and genetics business. The new range is produced under strict EU-GMP certified conditions and will be available in ten gram containers.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.